Efficacy of intradermal injection of tranexamic acid and ascorbic acid versus tranexamic acid and placebo in the treatment of melasma: A split-face comparative trial.

Nader PazyarSeyedeh Nasrin MolaviParisa HosseinpourMaryam HadibarhaghtalabSeyedeh Yasamin ParvarMotahareh Babazadeh Dezfuly

Published in: Health science reports (2022)

Intradermal injection of ascorbic acid combined with TA can be beneficial in treating melasma. Currently, there are numerous treatment modalities for melasma. However, the results still vary, and satisfactory outcomes are yet to be reached.

Keyphrases

clinical trial
study protocol
randomized controlled trial
metabolic syndrome
type diabetes
ultrasound guided
adipose tissue
replacement therapy
phase ii
smoking cessation